ISOQUINOLINYL-TRIAZOLON-KOMPLEXE
European patent · EP3436447 · Deleted
Register entry
- Publication number
- EP3436447
- Application number
- EP17719066
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Mar 30, 2017
- Published
- Feb 6, 2019
- Granted
- Jul 14, 2021
- Deleted
- Oct 23, 2026
- Reason
- Annual fee unpaid
- IPC classes
- C07D 401/14 (2006.01)A61K 31/4725 (2006.01)A61P 29/00 (2006.01)A61P 35/00 (2006.01)C08B 37/16 (2006.01)
- Priority
- US 201662316520 P 31.03.2016
- PCT application
- PCT/US2017/025076 30.03.2017
- PCT publication
- WO2017/173111 05.10.2017
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 23, 2026
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 23.10.2026
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 23.10.2026
- Apr 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.03.2025 → 31.03.2026
Published in Swissreg on 01.04.2025
- Apr 1, 2024
Change
Published in Swissreg on 01.04.2024
- Apr 1, 2023
Change
Published in Swissreg on 01.04.2023
- May 25, 2022
Change
Published in Swissreg on 25.05.2022
- Jul 14, 2021
Granted
Published in Swissreg on 14.07.2021
Parties
Holder
Takeda Pharmaceutical Company Limited
Osaka-shi, Osaka 541-0045, JP
Inventor
ZENG, Lu
San Diego California 92121, US
CHEN, Rongliang
San Diego California 92121, US
MANAM, Padma
San Diego California 92121, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.